INTRODUCTION
Bare metal stents are routinely used for treatment of arterial occlusive disease in many territories. Primary iliac stenting is a standard treatment for atherosclerotic disease of iliac arteries, widely used and associated with acceptable long-term patency rates.
Stent infection is a rare complication, particularly with the use of bare metal stents compared with covered stents. 1 This complication is associated with significant morbidity (17.2e73.5%) and mortality (32.5%). 2 This study reports a case of an iliac stent infection after treatment of in-stent restenosis, treated successfully by resection of the affected arterial segment and superficial femoral vein interposition. Potential risk factors are identified.
CASE REPORT
A 57 year old male, with a past medical history of hypertension, dyslipidaemia, current smoking habit, and peripheral arterial disease, was referred with Rutherford Classification category 3 chronic lower limb ischaemia. He presented with disabling left buttock and lower limb claudication.
Chronic total occlusion of the left common iliac artery was observed. Endovascular treatment was performed through percutaneous ipsilateral femoral access and a balloon expandable stent (9Â60mm; Assurant Cobalt Medtronic, Inc) was implanted. The patency of the iliac segment was restored without any complications. A satisfactory clinical result was achieved with resolution of claudication.
The patient remained asymptomatic for 4 years, at which time his claudication recurred. An iliac stent occlusion was identified and a secondary endovascular intervention was planned in the angiography suite. A drug coat coated balloon angioplasty of the iliac stent occlusion was performed via ipsilateral retrograde femoral access, using an In.Pact Pacific (Medtronic, Inc) 7Â80mm balloon. The control angiogram showed a suboptimal result with residual stenosis and a second 9Â57mm balloon expandable stent (BeSmooth Peripheral Stent, Bentley InnoMed GmbH) was implanted.
Thirteen days after this second intervention the patient developed fever associated with collapse and left lower limb tenderness and pain. On physical examination there were skin signs of distal embolisation in the left lower limb (Fig. 1) , extending to skin ulceration in some areas. The dorsalis pedis pulse was palpable.
Laboratory tests revealed a significant rise in inflammatory markers, with a C-reactive protein of 327mg/L, neutrophilic leukocytosis (18.7Â10 3 /mL leukocytes and 15.3Â10 3 /mL neutrophils), and D-dimers of 15815ng/mL.
Blood cultures were positive for methicillin sensitive Staphylococcus aureus. Echocardiography revealed no signs of endocarditis and no other organ involvement.
Computed tomography angiography showed a left common iliac artery pseudoaneurysm related to the stent implantation site, associated with peri-stent soft tissue inflammation (Fig. 2) .
The presence of an arterial pseudoaneurysm in the iliac stent position, associated with ipsilateral septic embolisation and positive blood cultures, confirmed the diagnosis of iliac stent infection and surgical treatment was planned.
The patient started on broad antibiotic therapy with piperacillin/tazobactam (4g/500mg 8 hourly) and vancomycin (1gr 12 hourly) subsequently adjusted to ciprofloxacin (750mg 12 hourly) based on the antimicrobial sensitivity testing.
Resection of the implanted material and affected arterial segment and in situ reconstruction with autologous venous conduit was planned. The right superficial femoral vein was harvested (Fig. 3) and transperitoneal aorto-iliac exposure was performed through a midline laparotomy. The left common iliac artery showed signs of infection. After systemic heparinisation with 5000 IU heparin, the infrarenal aorta and iliac arteries were clamped and the affected segment was resected along with all implanted material. After thorough cleansing of the surrounding tissue with saline solution, an interposition vein graft was constructed restoring patency of the left iliac segment (Fig. 4) .
The post-operative recovery was uncomplicated and the patient was discharged 15 days after surgery with decreased inflammatory markers (8.0Â10 3 /mL leukocytes and a CRP of 52.4mg/L). The patient remained on antibiotic therapy with ciprofloxacin (750mg; q12hr) for 14 days after surgery. Microbiology culture of the stent was negative, probably because of the ongoing treatment with intravenous antibiotics.
The patient remains asymptomatic after 6 months, with no complaints of claudication, leg pain, or skin lesions, and with no oedema of the right leg. There is no evidence of recurrent infection.
DISCUSSION
Vascular stent infection can be associated with significant morbidity (17.2e75.3%), 2 and its definitive treatment may require a complex invasive surgical procedure, particularly in intra-abdominal and intra-thoracic positions which are associated with a mortality rate of 20e50%. 3 In 2013 Bosman et al. 2 reviewed all reports of intravascular bare metal stent infections, and identified 77 cases (29 coronary and 48 non-coronary). Common iliac artery stent infections represented 23.4% of the overall described cases. In the non-coronary group, the iliac segment was the territory most frequently involved in stent infection, followed by the femoral artery and the renal artery. 2 Most reported cases developed early, within 2 weeks of stent implantation. 3, 4 A break in sterile technique is suggested as the most likely cause in these early stent infections. This was also the case in the patient described here, in whom the temporal association between implant and onset of symptoms suggests procedural contamination as the aetiology. In 25% of cases the infection occurs at a later stage, months to years after stent placement. 3 The most prevalent agent isolated is Staphylococcus aureus, responsible for 83% of stent infections. 3, 5 Clinical presentation of a stent infection may include progressive arterial destruction with disruption and haemorrhage, pseudoaneurysm formation, septic embolisation, and stent thrombosis. 2,4e7 Pseudoaneurysm arterial degeneration is the most common radiological sign, found in 77.9% of stent infection cases. 2 In the present case, the stent remained patent, but there were signs of septic embolisation in the ipsilateral lower limb and an arterial pseudoaneurysm involving the common iliac stent was present.
The rarity and non-specific clinical manifestations mean that there is a delay in the diagnosis in 50.7% of cases.
2 A high level of suspicion is mandatory for a timely diagnosis. Stent infection should be considered in the differential diagnosis of bacteraemia and fever in a patient with a history of stent implantation, especially if within 2e4 weeks of the procedure. 2 A review of reported cases conducted by Hogg et al. 6 identified risk factors for stent infection. In the present case there were several potential risk factors: it followed a second intervention, prophylactic antibiotics were not administered, and a drug coated balloon was used prior to the second stent implantation. Another potential risk factor could be that the procedure was performed in the angiography suite, which is a less aseptic environment compared with the operating theatre.
Neointimal formation and the incorporation of the stent in the arterial wall is reported as a protective measure against stent infection.
4,7 Inhibition of neointimal hyperplasia, promoted by drug-eluting stents, is underlined as a risk factor for early infections. 2 In the case described here, the use of a drug coated balloon before implantation of the second stent could have played a role in the onset of the infection.
Open surgical repair is the preferred treatment option whenever possible. Other options include conservative therapy with antibiotics or an endovascular approach, both associated with considerable mortality rates (50e75%). 2, 5 The definitive treatment may include stent removal and vascular reconstruction. The use of autologous superficial femoral vein for in situ arterial reconstruction is a valid option with recognised advantages especially in an infected field. 5, 8 The femoral vein is a large calibre autogenous conduit with approximately the same diameter as the iliac artery and is robust, resisting recurrent infection better than prosthetic conduits or thin walled veins such as the saphenous vein. Superficial vein harvest however, adds complexity and time to the procedure, and may be associated with venous morbidity symptoms, such as leg oedema in less than one third of the cases (11e15.2%).
9,10 Allografts have also been used successfully as conduits, but can have limited availability and cost, and the durability seems inferior to autologous vein. 9 As an alternative, ligation and extra-anatomical femoro-femoral bypass has been described, but this has poor long-term results, 9 with the disadvantages of the risk of stump blowout and lower patency compared with in situ reconstruction.
CONCLUSION
Bare metal stent infection is a rare but serious condition that can result in significant morbidity. Resection of infected tissue and implanted material, and in situ reconstruction using autologous superficial femoral vein provides an effective and durable treatment. Identification of risk factors such as re-intervention and use of local antimitotic drugs, use of antibiotic prophylaxis, and strict compliance with sterility protocols may minimise the risk of stent infection.
